IRVINE, Calif., July 6, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the acquisition of the company by C. R. Bard, Inc. (NYSE:BCR) was completed today. Under the terms...
Kendall Law Group, a national securities firm, is investigating SenoRx, Inc. (NASDAQ: SENO) for shareholders in connection with the proposed sale of the Company to C. R. Bard...
Levi & Korsinsky is investigating the Board of Directors of SenoRx, Inc. (“SenoRx” or the “Company”) (NasdaqGM: SENO) for possible breaches of fiduciary duty and other...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/senorx) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of...
Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of SenoRx Inc. (“SenoRx” or the “Company”) (Nasdaq: SENO) arising from the Company’s...
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2010. Revenue for the quarter increased 4.3...
Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of SenoRx...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of SenoRx, Inc. (“SenoRx” or the “Company”) (NASDAQ:SENO...
IRVINE, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced it has entered into a definitive merger agreement with C. R. Bard (NYSE:BCR) at a price of $11 per...
IRVINE, Calif., April 8, 2010 (GLOBE NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will host its investor conference call to review its First Quarter 2010 financial results on...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales